Form 8-K - Current report:
SEC Accession No. 0001390478-14-000004
Filing Date
2014-01-14
Accepted
2014-01-14 17:10:00
Documents
4
Period of Report
2014-01-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K drreddyspartnership8-k.htm 8-K 50406
2 EXHIBIT exhibit991-drreddyspartner.htm EX-99.1 17184
3 GRAPHIC pressreleasegalenadrr_image1.jpg GRAPHIC 102112
4 GRAPHIC pressreleasegalenadrr_image2.jpg GRAPHIC 7088
  Complete submission text file 0001390478-14-000004.txt   219810
Mailing Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034
Business Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33958 | Film No.: 14528000
SIC: 2834 Pharmaceutical Preparations